Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study
| Image |  |
|---|---|
| Description | scientific article published on 6 October 2009 |
| Author/s |
author: Per-Uno Malmström Pekka Hellström |
| Publication date | October 6, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |